Email this article to a friend
Long acting β2 agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trials
-
* Corresponding author: Don Husereau donh@ccohta.ca
- † Equal contributors
BMC Pulmonary Medicine 2004, 4:7 doi:10.1186/1471-2466-4-7